<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="116139">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02098668</url>
  </required_header>
  <id_info>
    <org_study_id>17721_PAEON</org_study_id>
    <nct_id>NCT02098668</nct_id>
  </id_info>
  <brief_title>Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON</brief_title>
  <acronym>PAEON</acronym>
  <official_title>Model Driven Computation for Infertility Related Endocrinological Diseases - PAEON</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <authority>Switzerland: Swissmedic</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Development of a bio-mathematical model of the human female cycle
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      From hormonal measurements throughout 1-2 menstrual cycles in women with and without
      endocrinological pathology a mathematical model of the human menstrual cycle will be
      generated. The model will serve to predict development of the cycle including ovulation as
      well as to better understand the pathophysiology of endocrinological disorder. In a second
      step current treatment protocols for fertility treatment will be integrated into the model
      in order to optimize treatment outcome.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Hormonal parameters</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Development of a mathematical model of the menstrual cycle</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dynamics of fertility treatment</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Mathematical model to improve fertility treatments</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Dynamics of gyneco-endocrinological diseases</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>To better understand the pathophysiological mechanisms in endocrinological diseases</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <condition>Endometriosis</condition>
  <condition>Hyperprolactinemia</condition>
  <arm_group>
    <arm_group_label>Normal, pathological cycle, infertility</arm_group_label>
    <description>healthy women PCOS Endometriosis hyperprolactinemia fertility treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fertility treatment</intervention_name>
    <description>Fertility treatment</description>
    <arm_group_label>Normal, pathological cycle, infertility</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Probes to determine hormonal parameters
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women with normal and distrubed menstrual cycles Women receiving fertility treatment
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

        - Women during their reproductive phase, no hormonal therapy

        Exclusion criteria:

        - Amenorrhoae
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Months</minimum_age>
    <maximum_age>43 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brigitte Leeners, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Division of Reproductive Endocrinology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brigitte Leeners, MD</last_name>
    <email>brigitte.leeners@usz.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Zurich, Division of Reproductive Endocrinology</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 25, 2014</lastchanged_date>
  <firstreceived_date>June 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>menstrual cycle dynamics</keyword>
  <keyword>PCOS</keyword>
  <keyword>hyperprolactinemia</keyword>
  <keyword>endometriosis</keyword>
  <keyword>infertility</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Endometriosis</mesh_term>
    <mesh_term>Hyperprolactinemia</mesh_term>
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
